Angelman syndrome: advancing the research frontier of neurodevelopmental disorders
Open Access
- 3 December 2010
- journal article
- research article
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 3 (1) , 50-56
Abstract
This report is a meeting summary of the 2010 Angelman Syndrome Foundation's scientific symposium on the neuroscience of UBE3A. Angelman syndrome is characterized by loss of speech, severe developmental delay, seizures, and ataxia. These core symptoms are caused by maternal allele disruptions of a single gene—UBE3A. UBE3A encodes an E3 ubiquitin ligase that targets certain proteins for proteasomal degradation. This biology has led to the expectation that the identification of Ube3a protein targets will lead to therapies for Angelman syndrome. The recent discovery of Ube3a substrates such as Arc (activity-regulated cytoskeletal protein) provides new insight into the mechanisms underlying the synaptic function and plasticity deficits caused by the loss of Ube3a. In addition to identifying Ube3a substrates, there have also been recent advances in understanding UBE3A's integrated role in the neuronal repertoire of genes and protein interactions. A developmental picture is now emerging whereby UBE3A gene dosage on chromosome 15 alters synaptic function, with deficiencies leading to Angelman syndrome and overexpression associated with classic autism symptomatology.Keywords
This publication has 29 references indexed in Scilit:
- EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse FormationCell, 2010
- Double‐blind therapeutic trial in Angelman syndrome using betaine and folic acidAmerican Journal of Medical Genetics Part A, 2010
- Loss of Arc renders the visual cortex impervious to the effects of sensory experience or deprivationNature Neuroscience, 2010
- The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating ArcCell, 2010
- The Arc of synaptic memoryExperimental Brain Research, 2009
- Defining the Human Deubiquitinating Enzyme Interaction LandscapeCell, 2009
- Genome-Wide Analysis of MEF2 Transcriptional Program Reveals Synaptic Target Genes and Neuronal Activity-Dependent Polyadenylation Site SelectionNeuron, 2008
- Novel Submicroscopic Chromosomal Abnormalities Detected in Autism Spectrum DisorderBiological Psychiatry, 2008
- De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndromeNature Genetics, 1997
- UBE3A/E6-AP mutations cause Angelman syndromeNature Genetics, 1997